News

Abbott announced it has received European CE Mark approval for the Esprit below-the-knee (BTK) everolimus-eluting resorbable ...
A summary of clinical outcomes from the Vascular and Endovascular Access Society (SAVE)* patient registry in Brazil, ...
Patient throughput and management of GI bleeds, from initial presentation through definitive management. Gastrointestinal (GI ...
A summary of my center’s experience in the WAVE pivotal trial, what makes the WRAPSODY Cell-Impermeable Endoprosthesis (CIE) ...
A Q&A addressing common questions around coding, payment models, and value-based care alignment for percutaneous transmural ...
Otsuka Medical Devices Co., Ltd. announced that the Paradise ultrasound renal denervation (uRDN) system has received manufacturi ...
Impact of the NCD on referrals and volumes of transfemoral carotid artery stenting, the multidisciplinary approach to evaluation and treatment, considering patient factors and patient preference, ...
Cook Medical announced that the FDA has granted approval for the company to initiate an investigational device exemption (IDE ...
Reflections on what is lost and gained when a well-designed trial produces unexpected results.
After the 2018 Journal of the American Heart Association (JAHA) meta-analysis suggesting an early mortality signal in ...
Michael Chen, MD Professor of Neurology, Neurosurgery & Radiology Rush University Medical Center Chicago, Illinois [email protected] ...
RenovoRx, Inc. announced an update of its ongoing pivotal phase 3 TIGeR-PaC trial, which is evaluating the company’s first ...